Biogen Message Board - Msg: 3390676

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 175.32

+4.2%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (593)	2/10/1998 12:37:00 PM
From: scaram(o)uche	Read Replies (1) of 1686

Idec is in the clinic, with an indication that seemingly plays into BGEN strength..... biz.yahoo.com Well, I guess, since it's only a phase I, that this (SLE) doesn't actually represent a chosen indication. It's just a safety trial where they may get an indication of efficacy. Still, this looks like bait for an infringement lawsuit. Something must (!) be going on with respect to cross-licensing, or there's something out there that I'm not seeing. Signed confused in CA, Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next